Cell-free translation of peptides and proteins: From high throughput screening to clinical production

Current Opinion in Chemical Biology

Volumn 17, Issue 3, 2013, Pages 420-426

  Murray, Christopher J ^a,b   Baliga, Ramesh ^a  

^a Sutro Biopharma Inc   (United States)

^b Galen Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CELL EXTRACT; CYCLIC GMP; NONNATURAL AMINO ACID; POLYPEPTIDE; RNA; UNCLASSIFIED DRUG;

GENETIC CODE; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; HETEROLOGOUS EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; PEPTIDE LIBRARY; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW; RIBOSOME;

ANIMALS; CELL-FREE SYSTEM; GENETIC ENGINEERING; HUMANS; PEPTIDES; PROTEIN BIOSYNTHESIS; RIBOSOMES; RNA, MESSENGER;

EID: 84878892481     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.02.014     Document Type: Review

References (55)

1. Nirenberg M.W., Matthaei J.H. The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. Proc Natl Acad Sci U S A 1961, 47:1588-1602.
2. Korostelev A., Trakhanov S., Laurberg M., Noller H.F. Crystal structure of a 70S ribosome-tRNA complex reveals functional interactions and rearrangements. Cell 2006, 126:1065-1077.
3. Brandt F., Etchells S.A., Ortiz J.O., Elcock A.H., Hartl F.U., Baumeister W. The native 3D organization of bacterial polysomes. Cell 2009, 136:261-271.
4. Shimizu Y., Inoue A., Tomari Y., Suzuki T., Yokogawa T., Nishikawa K., Ueda T. Cell-free translation reconstituted with purified components. Nat Biotechnol 2001, 19:751-755.
5. Karzbrun E., Shin J., Bar-Ziv R.H., Noireaux V. Coarse-grained dynamics of protein synthesis in a cell-free system. Phys Rev Lett 2011, 106:048104.
6. Forster A.C., Tan Z., Nalam M.N., Lin H., Qu H., Cornish V.W., Blacklow S.C. Programming peptidomimetic syntheses by translating genetic codes designed de novo. Proc Natl Acad Sci U S A 2003, 100:6353-6357.
7. Jewett M.C., Calhoun K.A., Voloshin A., Wuu J.J., Swartz J.R. An integrated cell-free metabolic platform for protein production and synthetic biology. Mol Syst Biol 2008, 4:220.
8. Tawfik D.S., Griffiths A.D. Man-made cell-like compartments for molecular evolution. Nat Biotechnol 1998, 16:652-656.
9. Ramachandran N., Hainsworth E., Bhullar B., Eisenstein S., Rosen B., Lau A.Y., Walter J.C., LaBaer J. Self-assembling protein microarrays. Science 2004, 305:86-90.
10. Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R., Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., et al. Human protein factory for converting the transcriptome into an in vitro-expressed proteome. Nat Methods 2008, 5:1011-1017.
11. Mattheakis L.C., Bhatt R.R., Dower W.J. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci U S A 1994, 91:9022-9026.
12. Roberts R.W., Szostak J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci U S A 1997, 94:12297-12302.
13. Josephson K., Hartman M.C., Szostak J.W. Ribosomal synthesis of unnatural peptides. J Am Chem Soc 2005, 127:11727-11735.
14. Zawada J.F., Yin G., Steiner A.R., Yang J., Naresh A., Roy S.M., Gold D.S., Heinsohn H.G., Murray C.J. Microscale to manufacturing scale-up of cell-free cytokine production-a new approach for shortening protein production development timelines. Biotechnol Bioeng 2011, 108:1570-1578.
15. Takai K., Sawasaki T., Endo Y. Practical cell-free protein synthesis system using purified wheat embryos. Nat Protoc 2010, 5:227-238.
16. Kovtun O., Mureev S., Jung W., Kubala M.H., Johnston W., Alexandrov K. Leishmania cell-free protein expression system. Methods 2011, 55:58-64.
17. Zhou Y., Asahara H., Gaucher E.A., Chong S. Reconstitution of translation from Thermus thermophilus reveals a minimal set of components sufficient for protein synthesis at high temperatures and functional conservation of modern and ancient translation components. Nucleic Acids Res 2012, 40:7932-7945.
18. Mikami S., Kobayashi T., Masutani M., Yokoyama S., Imataka H. A human cell-derived in vitro coupled transcription/translation system optimized for production of recombinant proteins. Protein Expr Purif 2008, 62:190-198.
19. Wang H.H., Huang P.-Y., Xu G., Haas W., Marblestone A., Li J., Gygi S.P., Forster A.C., Jewett M.C., Church G.M. Multiplexed in vivo His-tagging of enzyme pathways for in vitro single-pot multienzyme catalysis. ACS Synth Biol 2012, 1:43-52.
20. Kozlov I.A., Thomsen E.R., Munchel S.E., Villegas P., Capek P., Gower A.J.K., Pond S.J., Chudin E., Chee M.S. A highly scalable peptide-based assay system for proteomics. PLoS ONE 2012, 7:e37441.
21. Fujimori S., Hirai N., Ohashi H., Masuoka K., Nishikimi A., Fukui Y., Washio T., Oshikubo T., Yamashita T., Miyamoto-Sato E. Next-generation sequencing coupled with a cell-free display technology for high-throughput production of reliable interactome data. Sci Rep 2012, 2:691. 610.1038/srep00691.
22. Ramirez A.B., Loch C.M., Zhang Y., Liu Y., Wang X., Wayner E.A., Sargent J.E., Sibani S., Hainsworth E., Mendoza E.A., et al. Use of a single-chain antibody library for ovarian cancer biomarker discovery. Mol Cell Proteomics 2010, 9:1449-1460.
23. He M., Stoevesandt O., Taussig M.J. In situ synthesis of protein arrays. Curr Opin Biotechnol 2008, 19:4-9.
24. Schaerli Y., Hollfelder F. The potential of microfluidic water-in-oil droplets in experimental biology. Mol Biosyst 2009, 5:1392-1404.
25. Hanes J., Pluckthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci U S A 1997, 94:4937-4942.
26. Thom G., Cockroft A.C., Buchanan A.G., Candotti C.J., Cohen E.S., Lowne D., Monk P., Shorrock-Hart C.P., Jermutus L., Minter R.R. Probing a protein-protein interaction by in vitro evolution. Proc Natl Acad Sci U S A 2006, 103:7619-7624.
27. Fennell B.J., Darmanin-Sheehan A., Hufton S.E., Calabro V., Wu L., Muller M.R., Cao W., Gill D., Cunningham O., Finlay W.J. Dissection of the IgNAR V domain: molecular scanning and orthologue database mining define novel IgNAR hallmarks and affinity maturation mechanisms. J Mol Biol 2010, 400:155-170.
28. Yamaguchi J., Naimuddin M., Biyani M., Sasaki T., Machida M., Kubo T., Funatsu T., Husimi Y., Nemoto N. cDNA display: a novel screening method for functional disulfide-rich peptides by solid-phase synthesis and stabilization of mRNA-protein fusions. Nucleic Acids Res 2009, 37:e108.
29. Parker M.H., Chen Y., Danehy F., Dufu K., Ekstrom J., Getmanova E., Gokemeijer J., Xu L., Lipovsek D. Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two. Protein Eng Des Sel 2005, 18:435-444.
30. Getmanova E.V., Chen Y., Bloom L., Gokemeijer J., Shamah S., Warikoo V., Wang J., Ling V., Sun L. Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem Biol 2006, 13:549-556.
31. Mamluk R., Carvajal I.M., Morse B.A., Wong H., Abramowitz J., Aslanian S., Lim A.C., Gokemeijer J., Storek M.J., Lee J., et al. Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2. MAbs 2010, 2:199-208.
32. Tolcher A.W., Sweeney C.J., Papadopoulos K., Patnaik A., Chiorean E.G., Mita A.C., Sankhala K., Furfine E., Gokemeijer J., Iacono L., et al. Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin. Clin Cancer Res 2011, 17:363-371.
33. Sumida T., Yanagawa H., Doi N. In vitro selection of fab fragments by mRNA display and gene-linking emulsion PCR. J Nucleic Acids 2012, Article ID 371379.
34. Larman H.B., Jing Xu G., Pavlova N.N., Elledge S.J. Construction of a rationally designed antibody platform for sequencing-assisted selection. Proc Natl Acad Sci U S A 2012, 109:18523-18528.
35. Olson C.A., Nie J., Diep J., Al-Shyoukh I., Takahashi T.T., Al-Mawsawi L.Q., Bolin J.M., Elwell A.L., Swanson S., Stewart R., et al. Single-round, multiplexed antibody mimetic design through mRNA display. Angew Chem Int Ed Engl 2012, 51:12449-12453.
36. Barendt P.A., Shah N.A., Barendt G.A., Sarkar C.A. Broad-specificity mRNA-rRNA complementarity in efficient protein translation. PLoS Genet 2012, 8:e1002598.
37. Chodorge M., Fourage L., Ravot G., Jermutus L., Minter R. In vitro DNA recombination by L-shuffling during ribosome display affinity maturation of an anti-Fas antibody increases the population of improved variants. Protein Eng Des Sel 2008, 21:343-351.
38. Yin G., Garces E., Yang J., Zhang J., Steiner A.R., Tran C., Roos C.S.B., Hudak S., Penta K., et al. Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system. MAbs 2012, 4:219-227.
39. Buchanan A., Ferraro F., Rust S., Sridharan S., Franks R., Dean G., McCourt M., Jermutus L., Minter R. Improved drug-like properties of therapeutic proteins by directed evolution. Protein Eng Des Sel 2012, 25:631-638.
40. Noren C.J., Anthony-Cahill S.J., Griffith M.C., Schultz P.G. A general method for site-specific incorporation of unnatural amino acids into proteins. Science 1989, 244:182-188.
41. Hohsaka T., Ashizuka Y., Taira H., Murakami H., Sisido M. Incorporation of nonnatural amino acids into proteins by using various four-base codons in an Escherichia coli in vitro translation system. Biochemistry 2001, 40:11060-11064.
42. Loscha K.V., Herlt A.J., Qi R., Huber T., Ozawa K., Otting G. Multiple-site labeling of proteins with unnatural amino acids. Angew Chem Int Ed Engl 2012, 51:2243-2246.
43. Hipolito C.J., Suga H. Ribosomal production and in vitro selection of natural product-like peptidomimetics: the FIT and RaPID systems. Curr Opin Chem Biol 2012, 16:196-203.
44. Xiao H., Murakami H., Suga H., Ferre-D'Amare A.R. Structural basis of specific tRNA aminoacylation by a small in vitro selected ribozyme. Nature 2008, 454:358-361.
45. Hartman M.C., Josephson K., Szostak J.W. Enzymatic aminoacylation of tRNA with unnatural amino acids. Proc Natl Acad Sci U S A 2006, 103:4356-4361.
46. Hartman M.C., Josephson K., Lin C.W., Szostak J.W. An expanded set of amino acid analogs for the ribosomal translation of unnatural peptides. PLoS ONE 2007, 2:e972.
47. Yamagishi Y., Shoji I., Miyagawa S., Kawakami T., Katoh T., Goto Y., Suga H. Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library. Chem Biol 2011, 18:1562-1570.
48. Guillen Schlippe Y.V., Hartman M.C.T., Josephson K., Szostak J.W. In vitro selection of highly modified cyclic peptides that act as tight binding inhibitors. J Am Chem Soc 2012, 134:10469-10477.
49. Guarino C., DeLisa M.P. A prokaryote-based cell-free translation system that efficiently synthesizes glycoproteins. Glycobiology 2012, 22:596-601.
50. May R.D., Monk P.D., Cohen E.S., Manuel D., Dempsey F., Davis N.H., Dodd A.J., Corkill D.J., Woods J., Joberty-Candotti C., et al. Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma. Br J Pharmacol 2012, 166:177-193.
51. Campochiaro P.A., Channa R., Berger B.B., Heier J.S., Brown D.M., Fiedler U., Hepp J., Stumpp M.T. Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase 1/2 study. Am J Ophthalmol 2012, 10.1016/j.ajo.2012.09.032.
52. Stahl A., Stumpp M.T., Schlegel A., Ekawardhani S., Lehrling C., Martin G., Gulotti-Georgieva M., Villemagne D., Forrer P., Agostini H.T., et al. Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications. Angiogenesis 2013, 16:101-111.
53. Ng P.P., Jia M., Patel K.G., Brody J.D., Swartz J.R., Levy S., Levy R. A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity. Proc Natl Acad Sci U S A 2012, 109:14526-14531.
54. Matsuda T., Furumoto S., Higuchi K., Yokoyama J., Zhang M.R., Yanai K., Iwata R., Kigawa T. Rapid biochemical synthesis of (11)C-labeled single chain variable fragment antibody for immuno-PET by cell-free protein synthesis. Bioorg Med Chem 2012, 20:6579-6582.
55. Stephenson HS, Yang J, Murray CJ, Thanos CT, manuscript in preparation.